Barriers to Treatment Access for Chronic Hepatitis C Virus Infection

July/August 2017
IAS–USA Topics in Antiviral Medicine

Current Issue
July/August 2017 (Volume 25, Issue 3)

This journal is intended to be a resource for physicians and other health care practitioners who are actively involved in the care of patients with HIV or other viral infections

Cases From the Field

Barriers to Treatment Access for Chronic Hepatitis C Virus Infection: A Case Series

Alexander J. Millman, MD; Boatemaa Ntiri-Reid, JD, MPH; Risha Irvin, MD, MPH; Maggie H. Kaufmann, MA, MPH; Andrew Aronsohn, MD; Jeffrey S. Duchin, MD; John D. Scott, MD, MSc; Claudia Vellozzi, MD, MPH

Abstract

Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process.
Full Article - Download PDF

Download the entire issue, or select individual articles below.

Cases From the Field

• Sustained Off-Treatment Response After Discontinuation of Long-Term Nucleos(t)ide Analogue Treatment in HBeAg-Seronegative Hepatitis B: A Case Series
  Marion Muche, MD; Ulrike Meyer, MD; Britta Siegmund, MD; Rajan Somasundaram, MD; Hans-Joerg Epple, MD

Special Contribution

• Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens
  David L. Wyles, MD; Annie F. Luetkemeyer, MD

Perspective

• Neurologic Complications in Persons With HIV Infection in the Era of Antiretroviral Therapy
  Dennis Kolson, MD, PhD